Document is current
Any future updates will be listed below
-
Authors
Aguirre-Ollinger, Gabriel https://orcid.org/0000-0003-3834-9171
Chua, Karen Sui Geok https://orcid.org/0000-0001-9809-3425
Ong, Poo Lee https://orcid.org/0000-0002-0910-6683
Kuah, Christopher Wee Keong https://orcid.org/0000-0001-6070-3187
Plunkett, Tegan Kate https://orcid.org/0009-0007-4596-1525
Ng, Chwee Yin https://orcid.org/0009-0008-9923-7679
Khin, Lay Wai https://orcid.org/0000-0001-9181-0372
Goh, Kim Huat https://orcid.org/0000-0001-7327-0106
Chong, Wei Binh https://orcid.org/0009-0002-1888-8813
Low, Jaclyn Ai Mei https://orcid.org/0009-0000-8241-6269
Mushtaq, Malaika https://orcid.org/0000-0001-5683-0757
Samkharadze, Tengiz https://orcid.org/0000-0003-2969-4555
Kager, Simone https://orcid.org/0000-0002-1160-1501
Cheng, Hsiao-Ju https://orcid.org/0000-0002-6203-4543
Hussain, Asif https://orcid.org/0009-0006-3991-301X
-
Funding
Funding for this research was provided by:
National Health Innovation Centre, Singapore (NHIC) Innovation to Industry (NHIC-I2I-2104007)
Temasek Foundation (TF REF: TF1920-ATC-01)
- License Information
-
More Information
Article History
Received: 5 July 2024
Accepted: 22 October 2024
First Online: 26 November 2024
Declarations
:
: Institutional review board approvals were obtained from National Healthcare Group (NHG 2021/00156). All participants gave written informed consent.
: Participant gave written consent for image in Fig. B.
: KSGC and CWKK both declare interests that they were not involved in participant screening, informed consent, participant recruitment, data analysis nor data safety monitoring due to their co-sharing royalties from H-Man co-development. AH declares interest as co-founder and CEO of the company leading the development of H-Man and was not involved in the concept, conduct of trial, data monitoring or analysis of results. The following authors have no competing interests: GAO, PLO, TKP, CYN, LWK, KHG, WBC, JAML, MM, TS, SK, HJC.
